FNA

Appointment of Stephen M. Deitsch as new Chief Financial Officer

Retrieved on: 
Thursday, April 4, 2024
Growth, CFO, Patient, Foot, Liver transplantation, IPO, Ankle, FNA, Management

OXFORD, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- OrganOx , a medical device company which is changing the paradigm in liver transplantation in the US and Europe with its groundbreaking normothermic machine perfusion technology, today announces that Stephen (Steve) M. Deitsch will be joining OrganOx as Chief Financial Officer (“CFO”) on April 8, 2024.

Key Points: 
  • OXFORD, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- OrganOx , a medical device company which is changing the paradigm in liver transplantation in the US and Europe with its groundbreaking normothermic machine perfusion technology, today announces that Stephen (Steve) M. Deitsch will be joining OrganOx as Chief Financial Officer (“CFO”) on April 8, 2024.
  • Steve’s leadership was instrumental in Paragon 28’s successful IPO on the NYSE in the fall of 2021.
  • Prior to Paragon 28, Steve held CFO roles in a range of public and privately held companies in both the US and Europe.
  • Craig Marshall, OrganOx Chief Executive Officer, said, “I am hugely looking forward to working with Steve as our new CFO.

Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024

Retrieved on: 
Thursday, April 4, 2024
Surgery, Health, Medical Devices, Paragon, Growth, CFO, Webcast, Knowledge, Foot, Ankle, FNA, Interim management, Interim, Audit committee

The Company concurrently announced the appointment of Kristina Wright as Interim CFO, effective April 3, 2024.

Key Points: 
  • The Company concurrently announced the appointment of Kristina Wright as Interim CFO, effective April 3, 2024.
  • Thomas Schnettler, lead independent director for Paragon 28, will assume the role of interim Chair of the Audit Committee.
  • The Company reaffirms its prior 2024 net revenue guidance and continues to expect 2024 net revenue to be $249 million to $259 million, representing 15.1% and 19.7% reported growth compared to 2023.
  • Paragon 28 will report first quarter 2024 financial results after market close on Wednesday, May 8, 2024.

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System

Retrieved on: 
Thursday, March 28, 2024
General Health, Health, Surgery, Medical Devices, Paragon, Surgeon, Mechanics, Foot, Ankle, Ligament, FNA, Creativity, Injury, Multimedia, Video game

View the full release here: https://www.businesswire.com/news/home/20240328312304/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240328312304/en/
    Figure 1: Anterior inferior tibiofibular ligament (“AITFL”) Repair Showing the Grappler® R3INFORCE™ Dynamic Anchor (left) and Grappler® Knotless Anchor (center).
  • The Grappler® R3INFORCE™ Extraosseous Repair System is sterile packed and includes all instrumentation needed to complete the case in multiple configurations, reducing waste and intraoperative complexity.
  • It offers surgeons a comprehensive, physiological, and anatomical reconstruction system for ankle syndesmotic injuries.”
    The Grappler® R3INFORCE™ Extraosseous Repair System bolsters Paragon 28’s soft tissue offering, which includes the Paratrooper™ Plantar Plate System, TenoTac™ 2.0 Soft Tissue Fixation System, Grappler® Interference Screw System, Grappler® Suture Anchor System, Grappler® Knotless Anchor System, Bridgeline™ Tape, R3ACT® Stabilization System, R3LEASE™ Stabilization System, and Mister Tendon™ Harvester.
  • With this comprehensive portfolio, Paragon 28® provides its customers with a single source to address their foot and ankle soft tissue needs.

Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance

Retrieved on: 
Thursday, February 29, 2024
General Health, Health, Surgery, Medical Devices, Paragon, Marketing, International, FNA, Growth, Foot, Research, Ankle, Webcast, Investment

Consolidated net revenue for the fourth quarter of 2023 was $60.6 million, representing 17.6% and 17.3% reported and constant currency growth, respectively, compared to the fourth quarter of 2022.

Key Points: 
  • Consolidated net revenue for the fourth quarter of 2023 was $60.6 million, representing 17.6% and 17.3% reported and constant currency growth, respectively, compared to the fourth quarter of 2022.
  • Gross profit margin was 74.5% for the fourth quarter of 2023 compared to 81.5% in the fourth quarter of 2022.
  • Net loss was $19.6 million for the fourth quarter of 2023, compared to a net loss of $38.8 million for the fourth quarter of 2022.
  • Paragon 28 will host a conference call to discuss fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, at 2:30 p.m. Mountain Time / 4:30 p.m. Eastern Time.

Florida’s Nonprofit State Association and Association of Grantmakers Elevate Florida’s Nonprofit and Philanthropic Community

Retrieved on: 
Friday, February 23, 2024
Public Policy, Government, Other Professional Services, Other Philanthropy, State, Local, Professional Services, Philanthropy, Fund Raising, Foundation, Economic development, Florida Chamber of Commerce, FNA, Growth, FPN, Commerce, Organization, Community, Workforce, Research, Management

Florida’s nonprofit and philanthropic sectors have been set up for success thanks to cutting-edge data from the Florida Nonprofit Alliance (FNA) and the Florida Philanthropic Network (FPN).

Key Points: 
  • Florida’s nonprofit and philanthropic sectors have been set up for success thanks to cutting-edge data from the Florida Nonprofit Alliance (FNA) and the Florida Philanthropic Network (FPN).
  • Florida is currently the only state in the country that has this level of data available for nonprofits.
  • The data sets include the transfer of wealth taking place in the state, the giving occurring in the state and growing generosity in those under 45.
  • The sector is planning for the future thanks to research like this,” said Sabeen Perwaiz, president & CEO, Florida Nonprofit Alliance.

HSS Florida Appoints Heather Woolf, RN as Vice President, HSS Palm Beach County

Retrieved on: 
Wednesday, February 21, 2024
PALM, Six Sigma, Health administration, National Association, Multimedia, Registered nurse, Quality of life, FNA, Hospital, Florida Atlantic University, Elective surgery, HSS, ACHE, Conference, Specialization, Disability, American College, News, Health, Nursing

WEST PALM BEACH, Fla., Feb. 21, 2024 /PRNewswire/ -- HSS Florida, part of world leader in orthopedics Hospital for Special Surgery, has appointed experienced executive and Registered Nurse Heather Woolf as Vice President and senior administrator for its teams and facilities in Palm Beach County.

Key Points: 
  • WEST PALM BEACH, Fla., Feb. 21, 2024 /PRNewswire/ -- HSS Florida, part of world leader in orthopedics Hospital for Special Surgery, has appointed experienced executive and Registered Nurse Heather Woolf as Vice President and senior administrator for its teams and facilities in Palm Beach County.
  • Founded in 1863 and headquartered in New York City, HSS is the world's leading academic medical system specialized in musculoskeletal health.
  • Before the opening of HSS West Palm Beach in 2020, thousands of Florida residents traveled each year for care at the HSS main campus in New York City.
  • "In Palm Beach County HSS is perfectly positioned at the intersection of the world's best quality of life, and the world's leading cause of disability: musculoskeletal conditions."

Paragon 28 to Present at the CG 2024 Musculoskeletal Conference

Retrieved on: 
Monday, February 12, 2024
General Health, Health, Medical Devices, Paragon, CFO, FNA, Foot, Ankle, Conference

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in a fireside chat at the CG 2024 Musculoskeletal Conference on Monday, February 12, 2024, at 1:00 p.m. Pacific Time / 2:00 p.m. Mountain Time.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in a fireside chat at the CG 2024 Musculoskeletal Conference on Monday, February 12, 2024, at 1:00 p.m. Pacific Time / 2:00 p.m. Mountain Time.
  • A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

Survey Finds Florida Nonprofit Sector Provides Vital Services but Needs Funding and Volunteers

Retrieved on: 
Friday, February 9, 2024
Professional Services, Philanthropy, Other Philanthropy, Fund Raising, Foundation, Social Services, Organization, Wells Fargo, FNA, Senior, Volunteering, Management

Florida Nonprofit Alliance (FNA), which advocates on behalf of nonprofits and seeks to create a more vibrant community for nonprofits, today released its 2023 Florida Nonprofits Survey report.

Key Points: 
  • Florida Nonprofit Alliance (FNA), which advocates on behalf of nonprofits and seeks to create a more vibrant community for nonprofits, today released its 2023 Florida Nonprofits Survey report.
  • “Approximately half of the nonprofits in Florida are run only by volunteers, and nonprofits provide programs and services in every county in the state.”
    Nonprofits also express the need for new sources of funding.
  • “The nonprofit sector in Florida is essential for the success of our communities,” said Kate Wilson, Senior Vice President of Philanthropy and Community Impact for Wells Fargo in Florida.
  • FNA has been conducting regular surveys within the Florida nonprofit sector since April of 2020.

Fannie Mae Priced $518.3 Million Multifamily DUS REMIC (FNA 2024-M2) Under Its GeMS Program

Retrieved on: 
Friday, February 9, 2024
Analytics, Fannie Mae, FNMA, FNA, Senior, Agency, OTCQB

WASHINGTON, Feb. 9, 2024 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) priced a $518.3 million Multifamily DUS® REMIC under its Fannie Mae Guaranteed Multifamily Structures (Fannie Mae GeMS™) program on January 31, 2024.

Key Points: 
  • WASHINGTON, Feb. 9, 2024 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) priced a $518.3 million Multifamily DUS® REMIC under its Fannie Mae Guaranteed Multifamily Structures (Fannie Mae GeMS™) program on January 31, 2024.
  • FNA 2024-M2 marks the first Fannie Mae GeMS issuance of 2024.
  • Due to ongoing market volatility, we prioritized a swift execution," said Dan Dresser, Senior Vice President, Multifamily Capital Markets, Pricing and Analytics.
  • All classes of FNA 2024-M2 are guaranteed by Fannie Mae with respect to the full and timely payment of interest and principal.

Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Retrieved on: 
Tuesday, February 6, 2024
General Health, Health, Medical Devices, Paragon, Foot, Webcast, FNA, Ankle

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the fourth quarter and full year 2023 after market close on Thursday, February 29, 2024.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the fourth quarter and full year 2023 after market close on Thursday, February 29, 2024.
  • The company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time.
  • Live audio of the webcast will be available on the “Investors” section of the company’s website at: ir.paragon28.com .
  • The webcast will be archived and available for replay for at least 90 days after the event.